OC-0242: A randomized phase II trial of concurrent chemo-RT of oral vinorelbine and 60 Gy or 66 Gy, in locally advanced NSCLC. (April 2015) - Hansen, O.; Knap, M.; Khalil, A.; Nyhus, C.; McCulloch, T.; Holm, B.; Brink, C.; Hoffmann, L.; Schytte, T.